from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1574/-

LFCtreatmentdescriptionclass of inhibitor

0.015

Amikacinug/mL Amikacintranslation

-0.046

Cap5-10ug/mL Capreomycintranslation

0.716

Rox10-50 ug/mL Roxithromycintranslation

-0.549

SM2-5 ug/mL Streptomycintranslation

-0.469

Tet5-10 ug/mL Tetracyclinetranslation

-0.329

Rif0.2-5ug/mL Rifampicintranscription

-0.116

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.146

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.546

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.120

CPZ10-50 ug/mL Chlorpromazinerespiration

0.006

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.259

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.244

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.056

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.220

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.021

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.248

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.020

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.009

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.069

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.378

KCN5-20 ug/mL Potassium cyaniderespiration

-0.493

NaN30.2-2 mM Sodium aziderespiration

0.517

Nigericin50 uM Nigericinrespiration

-0.152

TRC10-150 ug/mL Triclosanrespiration

1.984

TRZ10-25 ug/mL Thioridazinerespiration

4.482

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.071

menadione6-10 ug/mL Menadionerespiration

-0.358

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.486

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.107

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.600

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.675

NRP_1Non-replicating persistence stage 1dosRassociated

-0.265

Amp0.2mg/mL AmpicillincellWall

-0.234

Cephalexin20-100 ug/mL CephalexincellWall

-0.414

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.565

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.370

EMB10-20 ug/mL EthambutolcellWall

-0.227

Eta12-40 ug/mL EthionamidecellWall

-0.073

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.082

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.203

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.192

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.041

BZA0.12 mg/mL BenzamidearomaticAmides

-0.116

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.408

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.213

H2O24 mM hydrogen peroxideDNAdamaging

-0.387

Levo10 ug/mL LevofloxacinDNAdamaging

-0.345

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.885

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.200

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.631

UVUV-irradiationDNAdamaging

0.641

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.280

Antimycin12.5-50 ug/mL Antimycin A?

0.033

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.158

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.311

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.702

PA8240.2-2 ug/mL PA-824?

0.097

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.111

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.549

Verapamil50 uM Verapamil?

0.039

mercaptoethanol2 mM 2-Mercaptoethanol?

0.148

methoxatin10-20 ug/mL Methoxatin?